The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
Treatment
Substance Use in the LGBTQ+ Community: Reading List
Lesbian, Gay, Bisexual, Transgender and Queer (LGBTQ+) Pride month is celebrated each year during the month of June. Here you can find a list of resources and research on the topic of substance use among the LGBTQ+ community. 1) This report...
Highlights from the 2023 UNODC World Drug Report
ISSUP are pleased to present our Webinar on highlights from the 2023 edition of the UNODC World Drug Report.
Highlights from the 2023 UNODC World Drug Report
Join our upcoming Webinar presenting highlights from the 2023 edition of the UNODC World Drug Report.
Treatment of Co-Occurring Traumatic Stress and Substance Use Problems Among Adolescents: State of the Science and Future Directions
In this presentation, Dr Carla Danielson will:
1) Provide a brief overview of the overlap between trauma (particularly child maltreatment) and substance use, theoretical models linking these, and the critical importance of integrated approaches to treatment for these problems;
2) Note the challenges that have impeded progress in integrated approaches;
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023 Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
National DSD Integrated Programme and Web App ASSIST Launch
This launch event is in response to the call for integrated implementation of services in institutions of higher learning and colleges, especially, at the primary level of intervention by respective stakeholders to facilitate integrated early intervention and prevention programmes with a specific focus on social crime prevention, risky substance use, and gender-based violence.
Substance use disorders: a comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Abstract Substance use disorders (SUDs) are highly prevalent and impact individuals' health, well-being, and social functioning. Long-lasting changes in brain networks involved in reward, executive function, stress reactivity, mood, and...
SMART recovery for youth: a small, exploratory qualitative study examining the potential of a mutual-aid, peer support addictive behaviour change program for young people
Abstract Background SMART (Self-Management and Recovery Training) Recovery is a mutual-aid program informed by cognitive behaviour therapy and motivational interviewing that provides support for a range of addictive behaviours. SMART...
Strategies to Address Cocaine and Methamphetamine
Presented by Richard Rawson, PhD, Emeritus Professor in the Department of Psychiatry and Biobehavioral Science, UCLA School of Medicine and a Research Professor at the University of Vermont, this presentation provided an overview of the...